Drug Type Small molecule drug |
Synonyms Prolucin, UTP, INS 316 + [3] |
Target |
Action agonists |
Mechanism P2Y2 receptor agonists(Purinergic receptor P2Y2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H15N2O15P3 |
InChIKeyPGAVKCOVUIYSFO-XVFCMESISA-N |
CAS Registry63-39-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Phase 3 | - | 01 Apr 2001 | |
Respiratory Tract Infections | Phase 3 | - | - | |
Respiratory Tract Infections | Phase 3 | - | - | |
Lung Diseases, Interstitial | Phase 2 | - | 01 Jan 2003 | |
Bronchitis | Phase 2 | United States | - | |
Ciliary Motility Disorders | Phase 2 | United States | - | |
Cystic Fibrosis | Phase 2 | United States | - |